ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
Developing antibiotics for children: There are no easy answers
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
De-risking vaccine development: Insights spanning decades of experience
The 37,000-year view: Infections in Eurasia
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
IDSA White Paper on developing narrow-spectrum antimicrobials + editorial by G. Drusano
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet